Cart
sales@molnova.com
Ebalzotan
CAS No. 149494-37-1
Ebalzotan( —— )
Catalog No. M36161 CAS No. 149494-37-1
Ebalzotan (NAE 086) is a 5-HT1A receptor agonist that can be used to study depression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 751 | In Stock |
|
| 10MG | 1121 | In Stock |
|
| 25MG | 2014 | In Stock |
|
| 50MG | 2585 | In Stock |
|
| 100MG | 3441 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEbalzotan
-
NoteResearch use only, not for human use.
-
Brief DescriptionEbalzotan (NAE 086) is a 5-HT1A receptor agonist that can be used to study depression.
-
DescriptionEbalzotan (NAE 086) is a 5-HT1A receptor agonist that can be used to study depression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149494-37-1
-
Formula Weight318.45
-
Molecular FormulaC19H30N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC(C)C)(=O)C1=C2C(OC[C@H](N(CCC)C(C)C)C2)=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Spiroxatrine
Spiroxatrine (R 5188) is a selective and potent 5-HT1α and α2-adrenergic dual antagonist with sedative activity, and inhibitory effects on 5-HT1α, 5-HT1β, 5-HT2, and dopamine receptors.
-
Repinotan
Repinotan (BAY x 3702 free base) is an orally active, selective 5-HT1A receptor agonist that crosses the blood-brain barrier (BBB), exhibits neuroprotective activity, counteracts morphine-induced depression of ventilation in anesthetized rats, and may be used in studies of acute ischemic stroke and traumatic brain injury.
-
Osemozotan HCl
Osemozotan HCl (Osemozotan hydrochloride) is a novel and selective 5-HT1A receptor agonist that reduces methamphetamine-induced c-Fos expression in the medial prefrontal cortex and striatum.
